ESERX
Price
$34.03
Change
-$0.40 (-1.16%)
Updated
Nov 13 closing price
Net Assets
593.38M
GFACX
Price
$74.18
Change
-$1.66 (-2.19%)
Updated
Nov 13 closing price
Net Assets
340.4B
Interact to see
Advertisement

ESERX vs GFACX

Header iconESERX vs GFACX Comparison
Open Charts ESERX vs GFACXBanner chart's image
Eaton Vance Atlanta Capital Sel Eq R6
Price$34.03
Change-$0.40 (-1.16%)
VolumeN/A
Net Assets593.38M
American Funds Growth Fund of Amer C
Price$74.18
Change-$1.66 (-2.19%)
VolumeN/A
Net Assets340.4B
ESERX vs GFACX Comparison Chart in %
View a ticker or compare two or three
VS
ESERX vs. GFACX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESERX is a Buy and GFACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 340B vs. ESERX (593M). ESERX (0.00) and GFACX (0.00) have matching dividends . ESERX was incepted earlier than GFACX: ESERX (9 years) vs GFACX (25 years). GFACX (1.36) is less costly to investors than ESERX (0.75). GFACX is a more actively managed with annual turnover of: 25.00 vs. ESERX (2.00). GFACX has a lower initial minimum investment than ESERX: GFACX (250) vs ESERX (5000000). GFACX annual gain was more profitable for investors over the last year : 4.61 vs. ESERX (-12.23). GFACX return over 5 years is better than : 27.87 vs. ESERX (12.05).
ESERXGFACXESERX / GFACX
Total Expense Ratio0.751.3655%
Annual Report Gross Expense Ratio0.751.3655%
Fund Existence9 years25 years-
Gain YTD-5.86416.343-36%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets593M340B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year-12.234.61-265%
Returns for 3 years18.4956.1733%
Returns for 5 years12.0527.8743%
Returns for 10 yearsN/A75.78-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BAX18.70N/A
N/A
Baxter International
OFG40.72-0.03
-0.07%
OFG Bancorp
CVGW21.90-0.23
-1.04%
Calavo Growers
FBIOP6.53-0.27
-3.97%
Fortress Biotech
ACRV2.07-0.21
-9.21%
Acrivon Therapeutics